Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
CKD-510 by Novartis for Charcot-Marie-Tooth Disease: Likelihood of Approval
CKD-510 is under clinical development by Novartis and currently in Phase I for Charcot-Marie-Tooth Disease. According to GlobalData, Phase I...